Comment
doi: 10.1016/S2213-2600(15)00145-9.
Epub 2015 Apr 16.
Targeted therapy with inhaled corticosteroids in COPD according to blood eosinophil counts
Affiliations
- PMID: 25892351
- DOI: 10.1016/S2213-2600(15)00145-9
Item in Clipboard
Comment
Targeted therapy with inhaled corticosteroids in COPD according to blood eosinophil counts
Lancet Respir Med.
2015 Jun.
No abstract available
Comment on
-
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.Lancet Respir Med. 2015 Jun;3(6):435-42. doi: 10.1016/S2213-2600(15)00106-X. Epub 2015 Apr 12. Lancet Respir Med. 2015. PMID: 25878028 Clinical Trial.
Similar articles
-
Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD?Lancet Respir Med. 2015 Aug;3(8):e26. doi: 10.1016/S2213-2600(15)00258-1. Lancet Respir Med. 2015. PMID: 26282478 No abstract available.
-
Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD?--Authors' reply.Lancet Respir Med. 2015 Aug;3(8):e27. doi: 10.1016/S2213-2600(15)00259-3. Lancet Respir Med. 2015. PMID: 26282479 No abstract available.
-
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.Lancet Respir Med. 2015 Jun;3(6):435-42. doi: 10.1016/S2213-2600(15)00106-X. Epub 2015 Apr 12. Lancet Respir Med. 2015. PMID: 25878028 Clinical Trial.
-
Breo Ellipta: An Inhaled Fluticasone/ Vilanterol Combination for COPD.Med Lett Drugs Ther. 2013 Sep 2;55(1424):69-71, 45-8. Med Lett Drugs Ther. 2013. PMID: 26839934 Review. English, French. No abstract available.
-
Combination of fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease.Ann Pharmacother. 2014 Feb;48(2):250-7. doi: 10.1177/1060028013512615. Epub 2013 Nov 19. Ann Pharmacother. 2014. PMID: 24259654 Review.
Cited by
-
Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.Curr Drug Targets. 2018;19(16):1882-1896. doi: 10.2174/1389450119666180212120012. Curr Drug Targets. 2018. PMID: 29437007 Free PMC article. Review.
-
Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short.Int J Chron Obstruct Pulmon Dis. 2020 Apr 20;15:821-829. doi: 10.2147/COPD.S233462. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32368028 Free PMC article. Review.
-
Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).Respir Res. 2018 Apr 11;19(1):63. doi: 10.1186/s12931-018-0767-2. Respir Res. 2018. PMID: 29642882 Free PMC article.
-
Diagnostic accuracy of blood eosinophils in comparison to other common biomarkers for identifying sputum eosinophilia in patients with chronic cough.World Allergy Organ J. 2023 Sep 28;16(9):100819. doi: 10.1016/j.waojou.2023.100819. eCollection 2023 Sep. World Allergy Organ J. 2023. PMID: 37811398 Free PMC article.
-
The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.Int J Chron Obstruct Pulmon Dis. 2015 Oct 15;10:2207-17. doi: 10.2147/COPD.S91694. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26527869 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
